AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Lariago-DS Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Chloroquine (500mg)

Overview Lariago-DS Tablet

Malarex tablets combat malaria parasites, preventing and treating the infection. Its mechanism involves eliminating the causative parasite, halting disease progression. Dosage and duration should strictly adhere to your physician's instructions. Ingestion with food mitigates potential stomach discomfort. Consistent medication is crucial; premature cessation may lead to treatment failure and amplified side effects. Avoid doubling doses; instead, resume the regimen as scheduled. Mosquito avoidance is paramount: utilize insect repellent on exposed skin, spray indoor repellents, and wear light-colored, protective clothing after dusk. Potential adverse reactions include skin rash, headache, dizziness, vomiting, abdominal pain, diarrhea, appetite loss, and nausea. Persistent symptoms warrant medical consultation. Diabetics should inform their doctor, as Malarex may induce hypoglycemia, necessitating regular blood glucose monitoring. Blurred vision is possible; regular eye exams are advised. Prolonged use may necessitate periodic blood cell count monitoring. Report any unexplained bleeding, bruising, sore throat, fever, or fatigue to your doctor immediately.

Uses of Lariago-DS Tablet

Managing Malaria Infections

Major Benefits of Lariago-DS Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lariago-DS Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Lariago-DS Tablet:

  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Lariago-DS Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lariago-DS Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Lariago-DS Tablet works:

Malaria is effectively combated by Lariago-DS Tablets, an antiparasitic drug. Its mechanism involves elevating blood heme concentrations, a compound lethal to the malaria parasite, thereby eliminating the parasite and halting disease progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Lariago-DS Tablet has unknown safety implications. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Lariago-DS Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can generally use Lariago-DS tablets without safety concerns. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Lariago-DS Tablet side effects. These side effects can include blurry vision or difficulty focusing, potentially impacting safe driving.

KidneyKidneyCAUTION

Patients with kidney impairment should use Lariago-DS Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Lariago-DS Tablets. Dosage modifications may be necessary. Physician consultation is recommended. Routine liver function tests may be advisable during treatment.

What if you forget to take Lariago-DS Tablet :

Should you forget a Lariago-DS Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Lariago-DS Tablet

LabelValue
Chemical Classification 4-Aminoquinoline analog
Developing Habits No.
Treatment Category Ophthalmology
Behavior Class Aminoquinoline Antimalarials

FAQs on Lariago-DS Tablet

Lariago-DS tablets treat and prevent malaria.
Malaria symptoms can emerge within seven days of an infected mosquito bite, although the incubation period typically ranges from seven to eighteen days. Initial symptoms mimic the flu, encompassing chills, fever, muscle aches, vomiting, headache, and diarrhea.
Prolonged use of Lariago-DS Tablets, containing chloroquine, necessitates regular eye examinations. This is to monitor for potential side effects such as blurred vision, reading difficulties (including word loss), and the rare occurrence of retinopathy.
Tell your doctor if you have psoriasis before starting Lariago-DS Tablets, as it could worsen your condition.
This medication may cause common side effects such as stomach pain, nausea, vomiting, and headache. Taking it with food may lessen these effects.
Insufficient medical evidence supports chloroquine's effectiveness against COVID-19. Consequently, avoid using Lariago-DS tablets for COVID-19 treatment without a doctor's consultation.
Allow at least four hours between taking an antacid and other medications.
Initially approved for malaria treatment, hydroxychloroquine and chloroquine differ significantly in their side effect profiles. Hydroxychloroquine, with its lower incidence of side effects, enjoys wider current use. Furthermore, its therapeutic applications extend beyond malaria to include rheumatoid arthritis and lupus, unlike chloroquine.
Protect yourself from malaria by covering exposed skin, using mosquito nets and repellent to avoid bites. Consult your doctor about preventative medication; if prescribed, take the correct antimalarial tablets, at the correct dosage, and complete the entire course.
Lariago-DS tablets treat and prevent malaria.
Malaria symptoms can emerge as soon as seven days post-mosquito bite, though the incubation period typically ranges from seven to eighteen days. Initial symptoms mimic the flu, encompassing chills, fever, muscle aches, vomiting, headache, and diarrhea.
Prolonged use of Lariago-DS Tablets, containing chloroquine, necessitates regular eye examinations. This is to monitor for potential side effects such as blurred vision, difficulty reading (characterized by words seemingly disappearing), and, rarely, retinopathy.
Tell your doctor if you have psoriasis before starting Lariago-DS Tablets, as it could worsen your condition.
This medication may cause common side effects such as stomach pain, nausea, vomiting, and headache. Taking it with food may lessen these effects.
Insufficient medical evidence supports chloroquine's effectiveness against COVID-19. Consequently, do not use Lariago-DS tablets to treat COVID-19 without consulting your doctor.
Allow at least four hours between taking an antacid and other medications.
Initially approved to treat malaria, hydroxychloroquine is now favored over chloroquine due to chloroquine's higher incidence of side effects. Hydroxychloroquine also holds approvals for rheumatoid arthritis and lupus, unlike chloroquine.
Protect yourself from malaria by covering exposed skin, using mosquito nets and repellent to avoid bites. Consult your doctor about preventative medication; if prescribed, take the correct antimalarial tablets, at the correct dosage, and complete the entire course.
Lariago-DS Tablet
14
MRP 17
18% off